🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

75,69 EUR

Máx. histórico

110,88

546 días

Caída desde máximo

-31,74%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,75%

Cierre anterior

76,26

Rango de hoy

75,22 – 76,19

Volumen hoy

910.041

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,36 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 6 horas
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,44%
Fecha de pago Importe por participación
16/05/2011 2,5000 EUR
20/05/2010 2,4000 EUR
23/04/2009 2,2000 EUR
16/05/2008 2,0700 EUR
07/06/2007 1,7500 EUR
29/11/2006 0,2666 EUR
07/06/2006 1,5200 EUR
29/11/2005 0,2408 EUR
07/06/2005 1,2000 EUR
30/09/2004 0,0750 EUR
05/05/2004 1,4550 EUR
02/06/2003 0,8400 EUR
03/06/2002 0,6600 EUR
01/06/2001 0,4400 EUR
05/06/2000 0,3200 EUR
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/10/2011 49,63 50,56 49,43 50,19 +0,86% 2,27% 3.661.536
12/10/2011 49,40 50,18 49,34 49,76 +0,22% 1,69% 3.401.649
11/10/2011 49,49 49,81 49,23 49,65 -0,28% 1,17% 2.380.512
10/10/2011 49,54 50,03 49,40 49,79 +1,85% 1,26% 3.150.885
07/10/2011 49,19 49,63 48,37 48,88 -0,13% 2,57% 3.312.123
06/10/2011 48,44 48,98 48,17 48,95 +1,12% 1,67% 4.771.144
05/10/2011 49,30 49,47 47,87 48,41 +0,69% 3,25% 4.537.217
04/10/2011 48,48 48,69 47,68 48,07 -1,37% 2,07% 4.358.407
03/10/2011 48,19 48,99 48,16 48,74 -0,70% 1,73% 2.309.373
30/09/2011 49,31 49,55 48,76 49,08 -1,01% 1,61% 4.581.565
29/09/2011 48,95 50,21 48,70 49,58 +1,29% 3,07% 2.692.095
28/09/2011 48,88 50,39 48,75 48,95 -0,61% 3,37% 3.911.327
27/09/2011 48,61 49,25 47,96 49,25 +2,95% 2,65% 5.263.902
26/09/2011 45,96 48,49 45,94 47,84 +2,35% 5,53% 4.944.327
23/09/2011 46,75 46,89 45,28 46,74 +1,06% 3,45% 5.387.447
22/09/2011 46,74 46,99 45,27 46,25 -3,16% 3,68% 6.908.085
21/09/2011 48,73 48,73 47,75 47,75 -2,11% 2,00% 4.021.306
20/09/2011 47,26 48,89 47,00 48,78 +3,24% 4,00% 3.098.606
19/09/2011 47,86 47,90 46,96 47,25 -3,19% 1,97% 3.643.114
16/09/2011 48,01 48,81 47,69 48,81 +1,88% 2,33% 11.116.004
15/09/2011 47,33 48,67 47,13 47,91 +1,44% 3,26% 5.179.609
14/09/2011 45,95 47,33 45,95 47,23 +1,72% 3,00% 4.125.292
13/09/2011 47,04 47,31 45,49 46,43 -0,68% 3,88% 5.598.737
12/09/2011 46,26 46,80 45,54 46,74 -1,84% 2,73% 5.551.839
09/09/2011 48,24 48,73 47,62 47,62 -3,20% 2,31% 5.422.847
08/09/2011 49,60 50,00 48,78 49,20 -0,73% 2,45% 3.271.165
07/09/2011 49,43 50,04 49,27 49,56 +1,26% 1,55% 4.957.774
06/09/2011 47,88 49,31 47,86 48,94 +1,91% 3,02% 6.626.615
05/09/2011 48,05 48,92 47,44 48,03 -2,85% 3,08% 3.785.393
02/09/2011 50,52 50,66 49,23 49,43 -3,67% 2,83% 3.845.834